Metabolic syndrome component combinations and chronic kidney disease: The severance cohort study

Maturitas

Volumn 75, Issue 1, 2013, Pages 74-80

  Cho, Jeong Ae ^a   Lee, Sun Ju ^a   Reid, Easton A ^b   Jee, Sun Ha ^a  

^a Yonsei University   (South Korea)

^b Asia Pacific International University   (Thailand)

Author keywords

Blood pressure; Chronic kidney disease; Cohort study; Epidemiology; High density lipoprotein; Metabolic syndrome

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 84876447107     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.02.006     Document Type: Article

References (30)

1. Q. Zhang, and D. Rothenbacher Prevalence of chronic kidney disease in population-based studies: systematic review BMC Public Health 8 2008 117
2. A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death. Cardiovascular events, and hospitalization New England Journal of Medicine 351 2004 1296 1305
3. C.P. Wen, T.Y. Cheng, and M.K. Tsai All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan Lancet 371 9631 2008 2173 2182
4. N.D. Vaziri, M. Navab, and A.M. Fogelman HDL metabolism and activity in chronic kidney disease Nature Reviews Nephrology 6 2010 287 296
5. L. Packer, and E. Cadenas Oxidative stress and inflammatory, mechanisms in obesity, diabetes, and the metabolic syndrome 2008 CRC Press Boca Raton
6. G. Thomas, A.R. Sehgal, and S.R. Kashyap Metabolic syndrome and kidney disease: a systematic review and meta-analysis Clinical Journal of the American Society of Nephrology 6 2011 2364 2373
7. K. Klausen, J.K. Borch, and R.B. Feldt Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes Circulation 110 2004 32 35
8. J. Chen, D. Gu, c-S Chen, X. Wu, L. Lee Haamm, P. Muntner, V. Batuman, C.-H. Lee, P.K. Whelton, and He Jiang Association between the metabolic syndrome and chronic kidney disease in Chinese adults Nephrology, Dialysis, Transplantation 22 2007 1100 1106
9. C. Kitiyakara, S. Yamwong, and S. Cheepudomwit The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort Kidney International 71 2007 693 700
10. M. Kurella, J.C. Lo, and G.M. Chertow Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults Journal of the American Society of Nephrology 16 2005 2134 2140
11. F. Sun, Q. Tao, and S. Zhan Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort Nephrology 15 2010 84 92
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001; 285:2486-2497.
13. A. Mozumdar, and G. Liguori Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006 Diabetes Care 34 2011 216 219
14. S. Lim, H. Shin, J.H. Song, and S.H. Kwak Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007 Diabetes Care 34 2011 1323 1328
15. Chronic kidney disease prognosis consortium: association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
16. National kidney foundation (NKF): K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification American Journal of Kidney Diseases 39 2 (Suppl. 1) 2002 S1 S266
17. G.L. Bakris, E. Ritz, and World Kidney Day Steering Committee The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented Journal of clinical hypertension (Greenwich) 11 2009 144 147
18. C.S. Fox, M.G. Larson, and E.P. Leip Predictors of new-onset kidney diseases in a community-based population Journal of the American Medical Association 291 2004 844 850
19. T. Fujita Aldosterone in salt-sensitive hypertension and metabolic syndrome Journal of Molecular Medicine 86 2008 729 734
20. C.S. Fox, M.G. Larson, and E.P. Leip Glycemic status and development of kidney disease: the Framingham heart study Diabetes Care 28 2005 2436 2440
21. N.D. Vaziri, and K. Norris Lipid disorders and their relevance to outcomes in chronic kidney disease Blood Purification 31 2011 189 196
22. H. Moradi, M.V. Pahl, R. Elahimehr, and N.D. Vaziri Impaired antioxidant activity of HDL in chronic kidney disease Translational Research 153 2009 77 85
23. P. Muntner, J. Coresh, J.C. Smith, J. Eckfeldt, and M.J. Klag Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities study Kidney International 58 2000 293 301
24. J.R. Diamond, and M.J. Karnovsky Focal and segmental glomerulosclerosis. Analogies to atherosclerosis Kidney International 33 1988 917 924
25. N.D. Vaziri, H. Moradi, M.V. Pahl, A.M. Fogelman, and M. Navab In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide Kidney International 76 2009 437 444
26. D. Tripathy, P. Mohanty, and S. Dhindsa Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects Diabetes 52 12 2003 2882 2887
27. J. Chen, P. Muntner, and L.L. Hamm Insulin resistance and risk of chronic kidney disease in Nondiabetic US adults Journal of the American Society of Nephrology 14 2003 469 477
28. K. Iseki, Y. Ikemiya, and K. Kinjo Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney International 65 2005 1870 1876
29. J. Carrero Juan, Mutsert Renee de, Axelsson Jonas, and M. Dekkers Olaf Sex differences in the impact of diabetes on mortality in chronic dialysis patients Nephrology, Dialysis, Transplantation 26 2011 270 276
30. A. Rashidi, A. Ghanbarian, and F. Azizi Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population Clinical Journal of the American Society of Nephrology 2 2007 976 983